ID   IL15_HUMAN              Reviewed;         162 AA.
AC   P40933; D3DNZ2; O00440; O43512; Q495Z8; Q6FGX7; Q93058; Q9UBA3;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   18-JUN-2025, entry version 204.
DE   RecName: Full=Interleukin-15;
DE            Short=IL-15;
DE   Flags: Precursor;
GN   Name=IL15;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IL15-S48AA), AND FUNCTION.
RC   TISSUE=Bone marrow;
RX   PubMed=8178155; DOI=10.1126/science.8178155;
RA   Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S.,
RA   Fung V., Beers C., Richardson J., Schoenborn M.A., Ahdieh M., Johnson L.,
RA   Alderson M.R., Watson J.D., Anderson D.M., Giri J.G.;
RT   "Cloning of a T cell growth factor that interacts with the beta chain of
RT   the interleukin-2 receptor.";
RL   Science 264:965-968(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8932977; DOI=10.1006/cyto.1996.0089;
RA   Krause H., Jandrig B., Wernicke C., Bulfone-Paus S., Pohl T.,
RA   Diamantstein T.;
RT   "Genomic sequence and chromosomal location of the human interleukin-15 gene
RT   (IL15).";
RL   Cytokine 8:667-674(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IL15-S21AA).
RC   TISSUE=Lung cancer;
RX   PubMed=8668345;
RA   Meazza R., Verdiani S., Biassoni R., Coppolecchia M., Gaggero A.,
RA   Orengo A.M., Colombo M.P., Azzarone B., Ferrini S.;
RT   "Identification of a novel interleukin-15 (IL-15) transcript isoform
RT   generated by alternative splicing in human small cell lung cancer cell
RT   lines.";
RL   Oncogene 12:2187-2192(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IL15-S21AA).
RC   TISSUE=Testis;
RX   PubMed=9405632; DOI=10.1073/pnas.94.26.14444;
RA   Tagaya Y., Kurys G., Thies T.A., Losi J.M., Azimi N., Hanover J.A.,
RA   Bamford R.N., Waldmann T.A.;
RT   "Generation of secretable and nonsecretable interleukin 15 isoforms through
RT   alternate usage of signal peptides.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:14444-14449(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Meazza R., Ferrini S.;
RT   "Expression of two IL-15 mRNA isoforms in human tumors does not correlate
RT   with secretion: role of different signal peptides.";
RL   Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IL15-S21AA).
RA   Li C.;
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM IL15-S21AA).
RC   TISSUE=Cerebellum, and Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM IL15-S21AA).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS IL15-S48AA AND
RP   IL15-S21AA).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 49-162.
RC   TISSUE=Epidermis;
RA   Sorel M.A., Jacques Y.;
RT   "IL15 expression in human keratinocytes.";
RL   Submitted (OCT-1994) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   FUNCTION.
RX   PubMed=8026467; DOI=10.1002/j.1460-2075.1994.tb06576.x;
RA   Giri J.G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S.,
RA   Namen A., Park L.S., Cosman D., Anderson D.;
RT   "Utilization of the beta and gamma chains of the IL-2 receptor by the novel
RT   cytokine IL-15.";
RL   EMBO J. 13:2822-2830(1994).
RN   [13]
RP   FUNCTION.
RX   PubMed=7568001; DOI=10.1073/pnas.92.19.8705;
RA   Johnston J.A., Bacon C.M., Finbloom D.S., Rees R.C., Kaplan D., Shibuya K.,
RA   Ortaldo J.R., Gupta S., Chen Y.Q., Giri J.D.;
RT   "Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases
RT   by interleukins 2 and 15.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:8705-8709(1995).
RN   [14]
RP   FUNCTION.
RX   PubMed=9326248;
RA   Badolato R., Ponzi A.N., Millesimo M., Notarangelo L.D., Musso T.;
RT   "Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1
RT   production in human monocytes.";
RL   Blood 90:2804-2809(1997).
RN   [15]
RP   FUNCTION, AND INDUCTION BY INTERFERON-GAMMA.
RX   PubMed=10233906;
RA   Musso T., Calosso L., Zucca M., Millesimo M., Ravarino D., Giovarelli M.,
RA   Malavasi F., Ponzi A.N., Paus R., Bulfone-Paus S.;
RT   "Human monocytes constitutively express membrane-bound, biologically
RT   active, and interferon-gamma-upregulated interleukin-15.";
RL   Blood 93:3531-3539(1999).
RN   [16]
RP   FUNCTION.
RX   PubMed=15123770; DOI=10.1189/jlb.0605298;
RA   Ratthe C., Girard D.;
RT   "Interleukin-15 enhances human neutrophil phagocytosis by a Syk-dependent
RT   mechanism: importance of the IL-15Ralpha chain.";
RL   J. Leukoc. Biol. 76:162-168(2004).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 49-162 IN COMPLEX WITH ANTIBODY,
RP   AND DISULFIDE BONDS.
RX   PubMed=21167836; DOI=10.1016/j.jmb.2010.12.017;
RA   Lowe D.C., Gerhardt S., Ward A., Hargreaves D., Anderson M., Ferraro F.,
RA   Pauptit R.A., Pattison D.V., Buchanan C., Popovic B., Finch D.K.,
RA   Wilkinson T., Sleeman M., Vaughan T.J., Mallinder P.R.;
RT   "Engineering a high-affinity anti-IL-15 antibody: crystal structure reveals
RT   an alpha-helix in VH CDR3 as key component of paratope.";
RL   J. Mol. Biol. 406:160-175(2011).
RN   [18] {ECO:0007744|PDB:4GS7}
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 49-162, DISULFIDE BONDS, AND
RP   FUNCTION.
RX   PubMed=23104097; DOI=10.1038/ni.2449;
RA   Ring A.M., Lin J.X., Feng D., Mitra S., Rickert M., Bowman G.R.,
RA   Pande V.S., Li P., Moraga I., Spolski R., Ozkan E., Leonard W.J.,
RA   Garcia K.C.;
RT   "Mechanistic and structural insight into the functional dichotomy between
RT   IL-2 and IL-15.";
RL   J. Immunol. 13:1187-1195(2012).
CC   -!- FUNCTION: Cytokine that plays a major role in the development of
CC       inflammatory and protective immune responses to microbial invaders and
CC       parasites by modulating immune cells of both the innate and adaptive
CC       immune systems (PubMed:15123770). Stimulates the proliferation of
CC       natural killer cells, T-cells and B-cells and promotes the secretion of
CC       several cytokines (PubMed:8178155, PubMed:9326248). In monocytes,
CC       induces the production of IL8 and monocyte chemotactic protein 1/CCL2,
CC       two chemokines that attract neutrophils and monocytes respectively to
CC       sites of infection (PubMed:9326248). Unlike most cytokines, which are
CC       secreted in soluble form, IL15 is expressed in association with its
CC       high affinity IL15RA on the surface of IL15-producing cells and
CC       delivers signals to target cells that express IL2RB and IL2RG receptor
CC       subunits (PubMed:10233906, PubMed:23104097, PubMed:8026467). Binding to
CC       its receptor triggers the phosphorylation of JAK1 and JAK3 and the
CC       recruitment and subsequent phosphorylation of signal transducer and
CC       activator of transcription-3/STAT3 and STAT5 (PubMed:7568001). In mast
CC       cells, induces the rapid tyrosine phosphorylation of STAT6 and thereby
CC       controls mast cell survival and release of cytokines such as IL4 (By
CC       similarity). {ECO:0000250|UniProtKB:P48346,
CC       ECO:0000269|PubMed:10233906, ECO:0000269|PubMed:15123770,
CC       ECO:0000269|PubMed:23104097, ECO:0000269|PubMed:7568001,
CC       ECO:0000269|PubMed:8026467, ECO:0000269|PubMed:8178155,
CC       ECO:0000269|PubMed:9326248}.
CC   -!- INTERACTION:
CC       P40933; Q13261: IL15RA; NbExp=5; IntAct=EBI-980274, EBI-980354;
CC       P40933; P14784: IL2RB; NbExp=3; IntAct=EBI-980274, EBI-2866779;
CC   -!- SUBCELLULAR LOCATION: [Isoform IL15-S48AA]: Secreted.
CC   -!- SUBCELLULAR LOCATION: [Isoform IL15-S21AA]: Cytoplasm. Nucleus.
CC       Note=IL15-S21AA is not secreted, but rather is stored intracellularly,
CC       appearing in the nucleus and cytoplasmic components.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=IL15-S48AA;
CC         IsoId=P40933-1; Sequence=Displayed;
CC       Name=IL15-S21AA;
CC         IsoId=P40933-2; Sequence=VSP_002660;
CC   -!- TISSUE SPECIFICITY: Most abundant in placenta and skeletal muscle. It
CC       is also detected in the heart, lung, liver and kidney. IL15-S21AA is
CC       preferentially expressed in tissues such as testis and thymus.
CC   -!- INDUCTION: By interferon-gamma. {ECO:0000269|PubMed:10233906}.
CC   -!- SIMILARITY: Belongs to the IL-15/IL-21 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA71044.1; Type=Miscellaneous discrepancy; Note=Man-made cDNA with a signal peptide sequence to increase protein secretion (substitution with a signal peptide derived from the mouse IgV kappa chain).; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Interleukin-15 entry;
CC       URL="https://en.wikipedia.org/wiki/Interleukin_15";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U14407; AAA21551.1; -; mRNA.
DR   EMBL; X91233; CAA62616.1; -; Genomic_DNA.
DR   EMBL; X94223; CAA63914.1; -; mRNA.
DR   EMBL; X94222; CAA63913.1; -; mRNA.
DR   EMBL; AF031167; AAB97518.1; -; mRNA.
DR   EMBL; Y09908; CAA71044.1; ALT_SEQ; mRNA.
DR   EMBL; AY720442; AAU21241.1; -; mRNA.
DR   EMBL; AK122993; BAG53839.1; -; mRNA.
DR   EMBL; AK290619; BAF83308.1; -; mRNA.
DR   EMBL; CR541980; CAG46777.1; -; mRNA.
DR   EMBL; CR542007; CAG46804.1; -; mRNA.
DR   EMBL; CH471056; EAX05083.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX05084.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX05085.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX05086.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX05087.1; -; Genomic_DNA.
DR   EMBL; BC018149; AAH18149.1; -; mRNA.
DR   EMBL; BC100961; AAI00962.1; -; mRNA.
DR   EMBL; BC100962; AAI00963.1; -; mRNA.
DR   EMBL; BC100963; AAI00964.1; -; mRNA.
DR   EMBL; Z38000; CAA86100.1; -; mRNA.
DR   CCDS; CCDS3755.1; -. [P40933-1]
DR   CCDS; CCDS3756.1; -. [P40933-2]
DR   RefSeq; NP_000576.1; NM_000585.5. [P40933-1]
DR   RefSeq; NP_751915.1; NM_172175.3. [P40933-2]
DR   PDB; 2XQB; X-ray; 2.60 A; A=49-162.
DR   PDB; 2Z3Q; X-ray; 1.85 A; A/C=49-162.
DR   PDB; 2Z3R; X-ray; 2.00 A; A/C/E/G/I/K/M/O=49-162.
DR   PDB; 4GS7; X-ray; 2.35 A; A=49-162.
DR   PDBsum; 2XQB; -.
DR   PDBsum; 2Z3Q; -.
DR   PDBsum; 2Z3R; -.
DR   PDBsum; 4GS7; -.
DR   AlphaFoldDB; P40933; -.
DR   SMR; P40933; -.
DR   BioGRID; 109813; 10.
DR   ComplexPortal; CPX-627; Interleukin-15 receptor-ligand complex.
DR   CORUM; P40933; -.
DR   DIP; DIP-3046N; -.
DR   FunCoup; P40933; 1048.
DR   IntAct; P40933; 8.
DR   STRING; 9606.ENSP00000296545; -.
DR   BindingDB; P40933; -.
DR   ChEMBL; CHEMBL3712954; -.
DR   DrugBank; DB01327; Cefazolin.
DR   GlyCosmos; P40933; 1 site, No reported glycans.
DR   GlyGen; P40933; 1 site.
DR   iPTMnet; P40933; -.
DR   PhosphoSitePlus; P40933; -.
DR   BioMuta; IL15; -.
DR   PaxDb; 9606-ENSP00000296545; -.
DR   ProteomicsDB; 55387; -. [P40933-1]
DR   ProteomicsDB; 55388; -. [P40933-2]
DR   ABCD; P40933; 5 sequenced antibodies.
DR   Antibodypedia; 3844; 1223 antibodies from 43 providers.
DR   DNASU; 3600; -.
DR   Ensembl; ENST00000296545.11; ENSP00000296545.7; ENSG00000164136.17. [P40933-1]
DR   Ensembl; ENST00000320650.9; ENSP00000323505.4; ENSG00000164136.17. [P40933-1]
DR   Ensembl; ENST00000394159.2; ENSP00000377714.1; ENSG00000164136.17. [P40933-2]
DR   Ensembl; ENST00000477265.5; ENSP00000436914.1; ENSG00000164136.17. [P40933-2]
DR   Ensembl; ENST00000514653.5; ENSP00000422271.1; ENSG00000164136.17. [P40933-2]
DR   Ensembl; ENST00000529613.5; ENSP00000435462.1; ENSG00000164136.17. [P40933-1]
DR   GeneID; 3600; -.
DR   KEGG; hsa:3600; -.
DR   MANE-Select; ENST00000320650.9; ENSP00000323505.4; NM_000585.5; NP_000576.1.
DR   UCSC; uc003iis.4; human. [P40933-1]
DR   AGR; HGNC:5977; -.
DR   CTD; 3600; -.
DR   DisGeNET; 3600; -.
DR   GeneCards; IL15; -.
DR   HGNC; HGNC:5977; IL15.
DR   HPA; ENSG00000164136; Low tissue specificity.
DR   MIM; 600554; gene.
DR   OpenTargets; ENSG00000164136; -.
DR   VEuPathDB; HostDB:ENSG00000164136; -.
DR   eggNOG; ENOG502SCMF; Eukaryota.
DR   GeneTree; ENSGT00390000016264; -.
DR   HOGENOM; CLU_135111_0_0_1; -.
DR   InParanoid; P40933; -.
DR   OMA; FVWGCIS; -.
DR   OrthoDB; 8905762at2759; -.
DR   PAN-GO; P40933; 7 GO annotations based on evolutionary models.
DR   PhylomeDB; P40933; -.
DR   PathwayCommons; P40933; -.
DR   Reactome; R-HSA-8983432; Interleukin-15 signaling.
DR   SignaLink; P40933; -.
DR   SIGNOR; P40933; -.
DR   BioGRID-ORCS; 3600; 6 hits in 1115 CRISPR screens.
DR   ChiTaRS; IL15; human.
DR   EvolutionaryTrace; P40933; -.
DR   GeneWiki; Interleukin_15; -.
DR   GenomeRNAi; 3600; -.
DR   Pharos; P40933; Tchem.
DR   PRO; PR:P40933; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; P40933; protein.
DR   Bgee; ENSG00000164136; Expressed in decidua and 152 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005768; C:endosome; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProt.
DR   GO; GO:0005794; C:Golgi apparatus; TAS:ProtInc.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005125; F:cytokine activity; IDA:UniProt.
DR   GO; GO:0005126; F:cytokine receptor binding; IEA:InterPro.
DR   GO; GO:0048469; P:cell maturation; IEA:Ensembl.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0045062; P:extrathymic T cell selection; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0035723; P:interleukin-15-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0048535; P:lymph node development; IEA:Ensembl.
DR   GO; GO:0030225; P:macrophage differentiation; IDA:ARUK-UCL.
DR   GO; GO:0001779; P:natural killer cell differentiation; IEA:Ensembl.
DR   GO; GO:0001787; P:natural killer cell proliferation; IEA:Ensembl.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0042119; P:neutrophil activation; IDA:UniProtKB.
DR   GO; GO:0001866; P:NK T cell proliferation; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; TAS:ProtInc.
DR   GO; GO:0001819; P:positive regulation of cytokine production; IBA:GO_Central.
DR   GO; GO:0050778; P:positive regulation of immune response; IBA:GO_Central.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; IDA:BHF-UCL.
DR   GO; GO:0032825; P:positive regulation of natural killer cell differentiation; IEA:Ensembl.
DR   GO; GO:0032819; P:positive regulation of natural killer cell proliferation; IEA:Ensembl.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IDA:UniProtKB.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IBA:GO_Central.
DR   GO; GO:0034105; P:positive regulation of tissue remodeling; IC:BHF-UCL.
DR   GO; GO:0050691; P:regulation of defense response to virus by host; IEA:Ensembl.
DR   GO; GO:0045580; P:regulation of T cell differentiation; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0007260; P:tyrosine phosphorylation of STAT protein; IDA:CACAO.
DR   FunFam; 1.20.1250.70:FF:000001; Interleukin; 1.
DR   Gene3D; 1.20.1250.70; Interleukin-15/Interleukin-21; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR020439; IL-15.
DR   InterPro; IPR003443; IL-15/IL-21_fam.
DR   InterPro; IPR020466; IL-15_mml.
DR   PANTHER; PTHR14356:SF3; INTERLEUKIN-15; 1.
DR   PANTHER; PTHR14356; INTERLEUKIN-15-RELATED; 1.
DR   Pfam; PF02372; IL15; 1.
DR   PRINTS; PR01947; INTLKN15MAML.
DR   PRINTS; PR01930; INTRLEUKIN15.
DR   SUPFAM; SSF47266; 4-helical cytokines; 1.
DR   neXtProt; NX_P40933; -.
DR   PharmGKB; PA29790; -.
DR   TreeFam; TF336199; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytokine; Cytoplasm; Disulfide bond;
KW   Glycoprotein; Nucleus; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..29
FT                   /evidence="ECO:0000255"
FT   PROPEP          30..48
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000015393"
FT   CHAIN           49..162
FT                   /note="Interleukin-15"
FT                   /id="PRO_0000015394"
FT   CARBOHYD        127
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        83..133
FT                   /evidence="ECO:0000269|PubMed:21167836,
FT                   ECO:0000269|PubMed:23104097"
FT   DISULFID        90..136
FT                   /evidence="ECO:0000269|PubMed:21167836,
FT                   ECO:0000269|PubMed:23104097"
FT   VAR_SEQ         1..37
FT                   /note="MRISKPHLRSISIQCYLCLLLNSHFLTEAGIHVFILG -> MVLGTIDLCS
FT                   (in isoform IL15-S21AA)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:8668345,
FT                   ECO:0000303|PubMed:9405632, ECO:0000303|Ref.6,
FT                   ECO:0000303|Ref.8"
FT                   /id="VSP_002660"
FT   CONFLICT        141
FT                   /note="E -> K (in Ref. 4; AAB97518)"
FT                   /evidence="ECO:0000305"
FT   HELIX           49..64
FT                   /evidence="ECO:0007829|PDB:2Z3Q"
FT   STRAND          73..75
FT                   /evidence="ECO:0007829|PDB:2Z3Q"
FT   HELIX           81..83
FT                   /evidence="ECO:0007829|PDB:2Z3Q"
FT   HELIX           84..102
FT                   /evidence="ECO:0007829|PDB:2Z3Q"
FT   HELIX           105..119
FT                   /evidence="ECO:0007829|PDB:2Z3Q"
FT   HELIX           136..138
FT                   /evidence="ECO:0007829|PDB:2Z3Q"
FT   STRAND          139..142
FT                   /evidence="ECO:0007829|PDB:2Z3Q"
FT   HELIX           144..158
FT                   /evidence="ECO:0007829|PDB:2Z3Q"
SQ   SEQUENCE   162 AA;  18086 MW;  0CE0520C1D8379E2 CRC64;
     MRISKPHLRS ISIQCYLCLL LNSHFLTEAG IHVFILGCFS AGLPKTEANW VNVISDLKKI
     EDLIQSMHID ATLYTESDVH PSCKVTAMKC FLLELQVISL ESGDASIHDT VENLIILANN
     SLSSNGNVTE SGCKECEELE EKNIKEFLQS FVHIVQMFIN TS
//
